Regenxbio RGNX Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's change in accrued liabilities?
- Regenxbio (RGNX) reported change in accrued liabilities of -$16.73M in Q1 2026.
- How has Regenxbio's change in accrued liabilities changed year-over-year?
- Regenxbio's change in accrued liabilities decreased by 15.5% year-over-year, from -$14.49M to -$16.73M.
- What is the long-term trend for Regenxbio's change in accrued liabilities?
- Over 2 years (2021 to 2025), Regenxbio's change in accrued liabilities has grown at a -91.2% compound annual growth rate (CAGR), from $29.91M to $229K.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.